Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Zimmer Biomet Holdings, Inc.

Market Cap 17.13B 14.8B 13.64B 12.77B 23.92B 1,629B 24.29B 161B 62.78B 793B 64.31B 62.94B 2,745B P/E Ratio 2026 *
17.9x
P/E Ratio 2027 * 15.8x
Enterprise Value 23.88B 20.63B 19.01B 17.79B 33.35B 2,270B 33.86B 224B 87.51B 1,105B 89.63B 87.73B 3,826B EV / Sales 2026 *
2.8x
EV / Sales 2027 * 2.57x
Free-Float
60.48%
Yield 2026 *
1.16%
Yield 2027 * 1.19%
1 day+1.64%
1 week+1.42%
Current month+7.58%
1 month+6.24%
3 months-4.34%
6 months-3.30%
Current year-1.50%
1 week 86.01
Extreme 86.01
90.5
1 month 81.58
Extreme 81.575
90.5
Current year 79.12
Extreme 79.12
101.49
1 year 79.12
Extreme 79.12
108.29
3 years 79.12
Extreme 79.12
147.5
5 years 79.12
Extreme 79.12
167.59
10 years 74.37
Extreme 74.37
180.36
Manager TitleAgeSince
Chief Executive Officer 50 21/08/2023
Director of Finance/CFO 51 27/04/2026
Chief Tech/Sci/R&D Officer - 13/04/2026
Director TitleAgeSince
Director/Board Member 70 11/02/2007
Director/Board Member 69 12/03/2008
Director/Board Member 70 31/12/2008
Date Insider Type Main position Quantity % Market Cap.
05-31Free

Executive/Senior Manager

1,857 0.0010%
05-28Sell

Executive/Senior Manager

-5,000 0.0026%
05-21Free

Director

2,392 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+1.64%+1.42%-5.03%-34.66% 17.13B
-1.64%-3.17%-35.38%-13.04% 154B
-0.16%-1.80%-9.37%-4.84% 103B
+0.07%+2.41%-4.53%+57.08% 54.8B
+3.00%+0.30%+55.27%+51.53% 55.22B
-0.75%-3.25%-16.18%-41.67% 40.3B
-1.40%+8.93% - - 30.96B
+0.16%+3.44%-9.03%-40.61% 29.08B
-0.46%+4.55%+46.20%-7.99% 23.23B
-2.85%-3.53%-16.97%-1.50% 20.25B
Average -0.07%+1.06%+0.56%-3.97% 52.75B
Weighted average by Cap. +0.09%-0.26%-7.78%-0.40%

Financials

2026 *2027 *
Net sales 8.54B 7.38B 6.8B 6.37B 11.93B 812B 12.11B 80.29B 31.31B 395B 32.06B 31.38B 1,369B 8.84B 7.63B 7.03B 6.58B 12.34B 840B 12.53B 83.05B 32.38B 409B 33.17B 32.46B 1,416B
Net income 925M 799M 736M 689M 1.29B 87.95B 1.31B 8.7B 3.39B 42.81B 3.47B 3.4B 148B 1.07B 924M 852M 797M 1.49B 102B 1.52B 10.06B 3.92B 49.5B 4.02B 3.93B 171B
Net Debt 6.75B 5.83B 5.37B 5.03B 9.42B 641B 9.57B 63.42B 24.73B 312B 25.33B 24.79B 1,081B 5.59B 4.83B 4.45B 4.16B 7.8B 531B 7.92B 52.51B 20.47B 258B 20.97B 20.52B 895B
Logo Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic reconstruction implants and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (67.4%): knees replacement (61.4% of net sales), hips replacement (38.6%); - surgical products and traumatology equipment (24.3%); - other (8.3%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2024, the group had approximately 25 production sites worldwide. Net sales are distributed geographically as follows: the United States (57.8%), Americas (4.7%), Europe/Middle East/Africa (22%) and Asia/Pacific (15.5%).
Employees
17,000
Date Price Change Volume
12/06/26 88.57 $ +1.64% 1,784,501
11/06/26 87.14 $ -1.17% 1,995,942
10/06/26 88.17 $ -1.63% 2,393,474
09/06/26 89.63 $ +2.70% 1,869,790
08/06/26 87.27 $ -0.07% 1,645,512
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
88.57USD
Average target price
98.70USD
Spread / Average Target
+11.44%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!